Pfizer Centers for Therapeutic Innovation (CTI) requests pre-proposals for biotherapeutic targets. The current submission deadline is June 28, 2021.
For more information, please email Jennifer Dyer or Donaldson Santos of the USC Stevens Center for Innovation, or call (213) 821-5002. Interested researchers must contact Jennifer or Donaldson with their availability for a brief phone call with the Pfizer CTI Director to discuss proposed concepts prior to submissions. No proposal shall be submitted without prior discussion with the researcher, USC Stevens Center for Innovation, and Pfizer CTI.
Objectives
Pfizer’s Center for Therapeutic Innovation collaborations focus around joint drug discovery where the investigator brings the target, validation and knowhow, and together with Pfizer a joint drug discovery research plan is developed. Pfizer’s areas of interest are aligned with their current core research areas of:
- Oncology
- Inflammation & Immunology
- Rare Diseases
- Internal Medicine
Details are outlined in the Call for Proposals (PDF).
Please visit the Pfizer CTI website for additional information about the program.